Examkin

Question

Difficulty: MediumHemodynamic and Coagulation Processes

A 48-year-old woman is brought to the emergency department due to a 3-day history of worsening confusion, generalized fatigue, and fever. Her medical history is unremarkable, and she takes no medications. Her temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 142/85 mm Hg142/85\text{ mm Hg}, and heart rate is 108/min108/\text{min}. Physical examination is notable for scleral icterus and scattered petechiae over her lower extremities. Neurological examination reveals mild disorientation but no focal motor or sensory deficits.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin7.6 g/dL7.6\text{ g/dL}12.0−16.0 g/dL12.0 - 16.0\text{ g/dL}
Platelets16,000/mm316,000/\text{mm}^3150,000−400,000/mm3150,000 - 400,000/\text{mm}^3
Creatinine1.5 mg/dL1.5\text{ mg/dL}0.6−1.1 mg/dL0.6 - 1.1\text{ mg/dL}
Total bilirubin3.8 mg/dL3.8\text{ mg/dL}0.1−1.2 mg/dL0.1 - 1.2\text{ mg/dL}
Indirect bilirubin3.1 mg/dL3.1\text{ mg/dL}0.1−0.8 mg/dL0.1 - 0.8\text{ mg/dL}
Lactate dehydrogenase (LDH)1,250 U/L1,250\text{ U/L}100−250 U/L100 - 250\text{ U/L}
Prothrombin time (PT)12.5 sec12.5\text{ sec}11−14 sec11 - 14\text{ sec}
Activated partial thromboplastin time (aPTT)30 sec30\text{ sec}25−40 sec25 - 40\text{ sec}

A presumptive diagnosis of thrombotic thrombocytopenic purpura (TTP) is made.

Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

  1. 1Review a peripheral blood smear for the presence of schistocytes.
  2. 2Draw a baseline blood sample for ADAMTS13 activity testing.
  3. 3Initiate emergent therapeutic plasma exchange (PLEX).
  4. 4Monitor daily platelet counts and lactate dehydrogenase (LDH) levels.

Answer

The correct chronological sequence for managing suspected TTP is to first confirm microangiopathic hemolytic anemia with a peripheral smear, then draw baseline ADAMTS13 labs before administering plasma, immediately initiate therapeutic plasma exchange (PLEX) without waiting for assay results, and finally monitor platelets and LDH daily to guide ongoing therapy.
The management of suspected thrombotic thrombocytopenic purpura (TTP) follows a strict, life-saving chronological sequence. The first step is to rapidly confirm microangiopathic hemolytic anemia by identifying schistocytes on a peripheral blood smear. Once MAHA and severe thrombocytopenia are confirmed with normal coagulation studies (PT/aPTT), the presumptive diagnosis of TTP is made. Next, a baseline blood sample for the ADAMTS13 activity assay must be drawn prior to any plasma administration. If drawn after plasma exchange has begun, the donor plasma will falsely replenish ADAMTS13 levels, permanently obscuring the true diagnostic baseline. Immediately after the baseline labs are drawn, emergent therapeutic plasma exchange (PLEX) must be initiated. Clinicians must not delay PLEX while waiting for the ADAMTS13 assay results to return. Finally, once PLEX is underway, daily monitoring of platelet counts and LDH is required to assess treatment response and determine when therapy can be safely discontinued.

Step-by-Step Solution

1
Review a peripheral blood smear.
Identifies schistocytes (fragmented red blood cells).
Rapidly confirms microangiopathic hemolytic anemia (MAHA), establishing the classic TTP pentad/dyad alongside thrombocytopenia and driving immediate clinical decision-making.
2
Draw ADAMTS13 activity assay.
Obtains baseline enzyme levels prior to intervention.
Must be collected strictly prior to plasma exchange; otherwise, donor plasma will falsely normalize the patient's ADAMTS13 levels and obscure the definitive diagnosis.
3
Initiate therapeutic plasma exchange (PLEX).
Removes pathogenic autoantibodies and replenishes functional ADAMTS13.
PLEX is life-saving and must be started emergently on clinical suspicion alone. Withholding therapy while waiting for ADAMTS13 lab results to return is associated with near-certain mortality.
4
Monitor daily platelets and LDH.
Assesses disease activity and treatment efficacy.
Guides the duration of PLEX therapy; daily exchange is typically continued until the platelet count normalizes and hemolysis parameters (LDH) resolve.

Key Concept

In the management of suspected thrombotic thrombocytopenic purpura (TTP), a baseline ADAMTS13 activity level must be drawn prior to administering plasma, followed by the immediate initiation of therapeutic plasma exchange (PLEX) without waiting for the ADAMTS13 assay results.
Estimated Time:1m 30s
Rate this question

Topics

Hemodynamic and Coagulation Processes

More questions from this topic